05:37 AM EDT, 09/19/2024 (MT Newswires) -- Qiagen ( QGEN ) said late Wednesday it launched 100 new assays for its QIAcuity digital polymerase chain reaction, or PCR, platform that can be used for food and environmental monitoring, infectious disease surveillance, and in studying cancer and genetic disorders.

The new assays are available through the company's GeneGlobe platform, pushing the number of assays that Qiagen ( QGEN ) launched this year to over 130, the company said.

Price: 45.70, Change: +0.02, Percent Change: +0.04